TRIMETH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimeth, and what generic alternatives are available?
Trimeth is a drug marketed by Alpharma Us Pharms, Naska, Avet Lifesciences, Lupin, Sun Pharm Industries, Am Regent, Hospira, Smith And Nephew, Solopak, Watson Labs, Dr Reddys Labs Sa, Novel Labs Inc, Novitium Pharma, Teva, Bausch And Lomb, Epic Pharma Llc, and Sandoz. and is included in twenty-four NDAs.
The generic ingredient in TRIMETH is polymyxin b sulfate; trimethoprim sulfate. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the polymyxin b sulfate; trimethoprim sulfate profile page.
Summary for TRIMETH
US Patents: | 0 |
Applicants: | 17 |
NDAs: | 24 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIMETH |
DailyMed Link: | TRIMETH at DailyMed |